827599-21-3

Basic information

• Product Name: endo-3-boc-3-azabicyclo[3.1.0]hexane-6-methanol
• Synonyms: endo-3-boc-3-azabicyclo[3.1.0]hexane-6-methanol
• CAS NO: 827599-21-3
• Molecular Formula: C11H19NO3
• Molecular Weight: 213.28
• Mol File: 827599-21-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: endo-3-boc-3-azabicyclo[3.1.0]hexane-6-methanol(CAS DataBase Reference)
• NIST Chemistry Reference: endo-3-boc-3-azabicyclo[3.1.0]hexane-6-methanol(827599-21-3)
• EPA Substance Registry System: endo-3-boc-3-azabicyclo[3.1.0]hexane-6-methanol(827599-21-3)

Safety Data

• Hazardous Substances Data: 827599-21-3(Hazardous Substances Data)

Usage

Uses

endo-3-Boc-3-azabicyclo[3.1.0]hexane-6-methanol is a useful reactant in organic synthesis.

Upstream product

• 1119512-39-8 rac-(1R,5S,6r)-3-(tert-butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid 
• 73286-70-1 N-(tert-butoxycarbonyl)-3-pyrroline 
• 827599-20-2 3-tert-butyl 6-ethyl (1R*,5S*,6S*)-3-azabicyclo[3.1.0]hexane-3,6-dicarboxylate 
• 1246025-66-0 [(1R,5S,65)-3-benzyl-3-azabicyclo[3.1.0]hexan-6-yl]methanol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 827599-22-4 (1R,5S,6r)-3-azabicyclo[3.1.0]hexane-6-methanol 

Relevant articles and documents

QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITOR, COMPOSITIONS, METHODS OF MAKING THEM AND THEIR USE

The present disclosure relates to new compounds or pharmaceutically acceptable salts or stereoisomers thereof of formula I as inhibitors of receptor tyrosine kinases (RTK), in particular extracellular mutants of ErbB-receptors. The present disclosure also relates to methods of preparation these compounds, compositions comprising these compounds, and methods of using them in the treatment of cancer in mammals (e.g. humans).

SERINE/THREONINE KINASE INHIBITORS

Compounds having the formula I wherein R1, R2, R3, R4, R5, Ra, Rb, Rc, Rd, Re, n, r, s and t are as defined herein and which compounds are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.

OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS

The present invention relates to certain substituted phenyl oxazolidinones of the formula h wherein T is a ring and to the processes for the synthesis of the same. The compounds are useful antimicrobial agents, effective against a number of human and v